These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38555760)

  • 1. Menopause transition and cardiovascular disease risk.
    Uddenberg ER; Safwan N; Saadedine M; Hurtado MD; Faubion SS; Shufelt CL
    Maturitas; 2024 Jul; 185():107974. PubMed ID: 38555760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
    El Khoudary SR; Aggarwal B; Beckie TM; Hodis HN; Johnson AE; Langer RD; Limacher MC; Manson JE; Stefanick ML; Allison MA;
    Circulation; 2020 Dec; 142(25):e506-e532. PubMed ID: 33251828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Disease in Women: Does Menopause Matter?
    El Khoudary SR; Nasr A
    Curr Opin Endocr Metab Res; 2022 Dec; 27():. PubMed ID: 37274015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding of and clinical approach to cardiometabolic transition at the menopause.
    Lambrinoudaki I; Armeni E
    Climacteric; 2024 Feb; 27(1):68-74. PubMed ID: 37224871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive aging, menopause, and health outcomes.
    Pinkerton JV; Stovall DW
    Ann N Y Acad Sci; 2010 Aug; 1204():169-78. PubMed ID: 20738288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
    Stevenson JC
    Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.
    Henderson VW; Brinton RD
    Prog Brain Res; 2010; 182():77-96. PubMed ID: 20541661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopause: a cardiometabolic transition.
    Nappi RE; Chedraui P; Lambrinoudaki I; Simoncini T
    Lancet Diabetes Endocrinol; 2022 Jun; 10(6):442-456. PubMed ID: 35525259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy.
    Tchernof A; Calles-Escandon J; Sites CK; Poehlman ET
    Coron Artery Dis; 1998; 9(8):503-11. PubMed ID: 9847982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia in midlife women: Approach and considerations during the menopausal transition.
    Torosyan N; Visrodia P; Torbati T; Minissian MB; Shufelt CL
    Maturitas; 2022 Dec; 166():14-20. PubMed ID: 36027726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal symptom management in women with cardiovascular disease or vascular risk factors.
    Hirsch H; Manson JE
    Maturitas; 2022 Jul; 161():1-6. PubMed ID: 35688488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease in Women Update: Ischemia, Diagnostic Testing, and Menopause Hormone Therapy.
    Prabakaran S; Vitter S; Lundberg G
    Endocr Pract; 2022 Feb; 28(2):199-203. PubMed ID: 34974184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, estrogens, and episodic memory in women.
    Henderson VW
    Cogn Behav Neurol; 2009 Dec; 22(4):205-14. PubMed ID: 19996872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women.
    Kim C
    Womens Health (Lond); 2012 Mar; 8(2):155-67. PubMed ID: 22375719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
    El Khoudary SR
    Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause, energy expenditure, and body composition.
    Poehlman ET
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):603-11. PubMed ID: 12190834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding weight gain at menopause.
    Davis SR; Castelo-Branco C; Chedraui P; Lumsden MA; Nappi RE; Shah D; Villaseca P;
    Climacteric; 2012 Oct; 15(5):419-29. PubMed ID: 22978257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat distribution, the menopause transition, and hormone replacement therapy.
    Tchernof A; Poehlman ET; Després JP
    Diabetes Metab; 2000 Feb; 26(1):12-20. PubMed ID: 10705099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.